drugset / Trial / NCT01875848
Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain
RandomizedParallel-groupOpen-labelTreatment
Summary
This study compares buprenorphine/naloxone to opioid dose escalation among patients with poorly controlled non-cancer pain on 30-100 mg daily morphine equivalent opioid dose.
Timeline
- Start
- 2013-12
- Primary completion
- 2015-06
- Completion
- 2015-06
Outcome
Outcome not reported
Stopped (Enrollment): “Data safety monitoring board recommended due to low recruitment yield.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |
| Subject | Naloxone | Small molecule | — | — |
Indications
No indication recorded.